Rediscovering the Role of Dopamine in Movement Control

A study led by researchers at McGill University and published in Nature Neuroscience proposes that dopamine does not act as the fine regulator of each movement, but rather as a condition of possibility for movement to occur. Instead of determining the speed or strength of a specific action, its function seems more basic: sustaining the motor system in an operational state.

This distinction is key to understanding why treatments such as levodopa improve Parkinson’s motor symptoms, even though the exact mechanism of their effectiveness had not been entirely clear. In recent years, the detection of rapid, brief increases in dopamine during movement led to the belief that these fluctuations were directly responsible for so-called “motor vigor.” The new study challenges that interpretation.

To explore this hypothesis, the team recorded brain activity in mice trained to press a weighted lever, while manipulating dopaminergic neuron activity in real time using optical techniques. If rapid dopamine peaks controlled movement intensity, altering their activity during the action should have changed motor performance. However, no significant differences were observed in either the speed or the strength of movements.

In additional tests with levodopa, researchers found that the drug does not restore those rapid fluctuations, but instead raises the brain’s baseline dopamine level. This suggests that the central problem in Parkinson’s may not be the absence of a precise dynamic signal, but rather the lack of a stable minimum level that allows the motor system to function normally.

From this perspective, dopamine does not operate as an accelerator defining how each movement is executed, but as an indispensable component enabling the entire mechanism to start. This conceptual reformulation not only clarifies how current treatments work, but also opens the possibility of developing therapies aimed at maintaining adequate baseline dopamine levels, rather than mimicking natural release patterns that may not be essential.

The results also invite reconsideration of previous therapeutic strategies, such as the use of dopaminergic agonists, which showed benefits but also adverse effects by acting too broadly. A more precise understanding of dopamine’s role could allow for more targeted and safer interventions, aligned with its real function in motor control.